Biocryst Pharmaceuticals (BCRX) Treasury Shares (2010 - 2026)

Biocryst Pharmaceuticals' Treasury Shares history runs 1 years deep, the most recent figure standing at $5000.0 for Q4 2010.

• Quarterly Treasury Shares rose 19.09% year-over-year to $10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.8 million (up 19.09% YoY) and the FY2025 annual result came in at $11.1 million, up 19.94% from the prior year.
• Treasury Shares was $10.8 million for Q1 2026 at Biocryst Pharmaceuticals, down from $11.1 million in the prior quarter.
• Across five years, Treasury Shares topped out at $11.1 million in Q4 2025 and bottomed at $813000.0 in Q1 2024.
• A 5-year average of $5.7 million and a median of $5.1 million in 2024 frame the typical range for Treasury Shares.
• Peak annual rise in Treasury Shares reached 1018.45% in 2025, while the deepest fall reached 82.87% in 2025.
• Biocryst Pharmaceuticals' Treasury Shares stood at $4.2 million in 2022, then surged by 34.46% to $5.6 million in 2023, then soared by 66.11% to $9.3 million in 2024, then gained by 19.94% to $11.1 million in 2025, then decreased by 2.8% to $10.8 million in 2026.
• Business Quant data shows BCRX's Treasury Shares at $10.8 million in Q1 2026, $11.1 million in Q4 2025, and $999000.0 in Q3 2025.